Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-24-000147
Filing Date
2024-01-02
Accepted
2024-01-02 16:47:06
Documents
2
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2988
2 POA DOCUMENT poa.txt EX-24 4039
  Complete submission text file 0001209191-24-000147.txt   8586
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Issuer) CIK: 0001671927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
GOLL JOHN (Reporting) CIK: 0001779466 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39992 | Film No.: 24503160